ADAR1 Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$75K Sell
2024
Q4
$263K Hold
2024
Q3
$266K Buy
2024
Q2
$182K Buy